Article
Suppression of B-Cell Activation by Human Cord Blood-Derived Stem Cells (CB-SC) through…
medRxiv · 2021 · Hu, W.; Song, X.; Yu, H.; Fan, S.; Shi, A.; Sun, J.; Wang, H.; Zhao, L.; Zhao, Y.
Key facts
| Title | Suppression of B-Cell Activation by Human Cord Blood-Derived Stem Cells (CB-SC) through the Galectin-9-Dependent Cell Contact Mechanism |
|---|---|
| First author | Hu, W.; Song, X.; Yu, H.; Fan, S.; Shi, A.; Sun, J.; Wang, H.; Zhao, L.; Zhao, Y. |
| Journal | medRxiv |
| Published | Oct 8, 2021 |
| DOI | 10.1101/2021.10.07.463564 |
| Devices mentioned | K073487, K073489, K073490, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184 and 4 more |
| Product codes mentioned | CEK, CFN, JJH, KIP, KIT, LEA, MVU, NJT, PPM |
At a glance
- 10–99 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1